1. Design

The market leaders in conventional bioreactor and aseptic mixing products have clearly perceived the advantages of these single-use bioreactors for decision-makers and managers:

• flexibility ;

• quick start ;

• lower initial capital investment ;

• no overcapacity: adapt capacity to demand ;

• no cross-contamination ;

• no on-site cleaning and sterilization, saving time for operators and money on cleaning and disinfection products and purified water;

• lower development costs ;

• shorter time-to-market.

For users, however, a number of risks remain:

• ...